Extracted from this filing and checked against the source text.
Material Agreements
SEC 8-K Item 1.01/1.02
confidence 0.95
AbCellera Biologics Inc. entered into Canada Contribution Agreement with Government of Canada valued at Up to $166.7 million (CA$225.0 million) including non-repayable, repayable, and conditionally repaya (effective 2023-05-24).
- Action
- entry
- Counterparty
- Government of Canada
- Value
- Up to $166.7 million (CA$225.0 million) including non-repayable, repayable, and conditionally repaya
- Effective
- 2023-05-24
Exact text from the filing
Pursuant to the Canada Contribution Agreement, the Government of Canada has committed up to $166.7 million (CA$225.0 million), of which $41.6 million (CA$56.2 million) is not repayable, $58.4 million (CA$78.8 million) is repayable and $66.7 million (CA$90.0 million) is conditionally repayable.
View on SEC.gov
Material Agreements
SEC 8-K Item 1.01/1.02
confidence 0.95
AbCellera Biologics Inc. entered into BC Contribution Agreement with Government of British Columbia valued at Up to $55.6 million (CA$75.0 million) including partial reimbursement and conditional portions. (effective 2023-05-24).
- Action
- entry
- Counterparty
- Government of British Columbia
- Value
- Up to $55.6 million (CA$75.0 million) including partial reimbursement and conditional portions.
- Effective
- 2023-05-24
Exact text from the filing
Pursuant to the BC Contribution Agreement, the Government of British Columbia has committed up to $55.6 million (CA$75.0 million) which includes partial reimbursement of certain eligible expenditures up to $27.8 million (CA$37.5 million) towards eligible infrastructure investments paid over five years; and a $27.8 million (CA$37.5 million) conditional portion paid upon achievement of certain defined milestones, including upon the Company’s undertaking of certain clinical trial activities in British Columbia.
View on SEC.gov